The Liver Meeting 2021-Are We Any Closer?

Video Transcription

Video Summary

Experts discussed progress, challenges, and strategies in viral hepatitis elimination at a session aiming to share insights from the response to COVID-19. Despite advancements in therapy, lack of funding remains a key barrier to achieving elimination targets. Successful countries like Georgia and Australia emphasized the importance of political commitment and simplification of diagnosis. Innovative financing methods, increased investment, and addressing barriers are crucial for improving treatment access and affordability. Integration of hepatitis treatment into existing healthcare systems, donor investments, and multi-sectoral approaches were highlighted as essential. The impact of COVID-19 on hepatitis care was discussed, emphasizing the opportunity to leverage pandemic response lessons to accelerate progress towards elimination goals.

Keywords

viral hepatitis

elimination

COVID-19

progress

challenges

strategies

therapy advancements

funding

political commitment

diagnosis simplification

innovative financing

treatment access

healthcare systems integration